Choose Orphanos for your rare disease trial
Orphanos, a division of Trial Runners, LLC is a rare disease CRO dedicated to clinical research in this rapidly growing market.
Orphanos’ unique study management solutions are tailored for the needs of clients investing in cures for rare disease indications and for those patients seeking treatment options. As a global CRO, our clinical operations group focuses on specialized patient recruitment solutions to meet your needs. Orphanos applies proven best practices to feasibility assessments, recruitment and retention solutions, and logistic management in order to execute the most efficient clinical study.
Learn more about the Orphanos difference here.